The ubiquitin-proteasome pathway: limitations and opportunities.
Attaix
Didier
D
Human Nutrition Research Center of Clermont-Ferrand, Nutrition and Protein Metabolism Unit, Ceyrat, France. attaix@clermont.inra.fr
Ventadour
Sophie
S
Taillandier
Daniel
D
Combaret
Lydie
L
D001798:Blood Proteins / Q000378:metabolism; D016207:Cytokines / Q000378:metabolism / Q000627:therapeutic use; D005938:Glucocorticoids / Q000378:metabolism / Q000627:therapeutic use; D006801:Humans; D009124:Muscle Proteins / Q000096:biosynthesis; D009133:Muscular Atrophy / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D046988:Proteasome Endopeptidase Complex / Q000378:metabolism*; D011509:Proteoglycans; D015398:Signal Transduction / Q000187:drug effects / Q000502:physiology; D014452:Ubiquitins / Q000378:metabolism*
D001798:Blood Proteins; D016207:Cytokines; D005938:Glucocorticoids; D009124:Muscle Proteins; D011509:Proteoglycans; D014452:Ubiquitins; C042057:proteolysis-inducing peptide; D046988:Proteasome Endopeptidase Complex